Is the business good?
How good a business is MTD?
Mettler Toledo keeps 22% of every revenue dollar as profit after everything, against 6.7% for the median Diagnostics & Research name.
22%
Net margin · Diagnostics & Research median 6.7% · 12 months to Q2 2026
- Cash conversion
- 0.95×
Cash conversion · 1.02× a year ago · some of the reported profit has not turned into cash yet
- Share count, year on year
- −2.8%
Share count, year on year · bought back, each share owns more of the company
- R&D as % of revenue
- 5.0%
R&D as % of revenue
Details›
- Gross margin12 months to Q2 2026
- 60%
- Net margin12 months to Q2 2026
- 22%
- Free cash flow margin
- 21%
- R&D as % of revenue
- 5.0%
- Revenue, trailing twelve months
- $4.13B
- Free cash flow, trailing twelve months
- $864M
- Net income, trailing twelve months
- $906M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Diagnostics & Research
Ranks #12 of 29 by Smart Score